Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H15NO5 |
| Molecular Weight | 181.187 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
InChI
InChIKey=SDOFMBGMRVAJNF-SLPGGIOYSA-N
InChI=1S/C6H15NO5/c7-1-3(9)5(11)6(12)4(10)2-8/h3-6,8-12H,1-2,7H2/t3-,4+,5+,6+/m0/s1
| Molecular Formula | C6H15NO5 |
| Molecular Weight | 181.187 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Perfluoroalkylated derivatives of 6-deoxy-6-ethylamino-D-galactose, 1-deoxy-1-methylamino-D-glucitol, and 1-amino-1-deoxy-D-glucitol: syntheses, hemocompatibility, and effect on perfluorocarbon emulsion. | 2010-05-27 |
|
| Chiral N-acyloxazolidines: synthesis, structure, and mechanistic insights. | 2008-01-18 |
|
| A family of hydrogels based on ureido-linked aminopolyol-derived amphiphiles and bolaamphiphiles: synthesis, gelation under thermal and sonochemical stimuli, and mesomorphic characterization. | 2008 |
|
| Highly sensitive simultaneous detection of cultured cellular thiols by laser induced fluorescence-capillary electrophoresis. | 2005-03 |
|
| Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing. | 1990-06 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:27:40 GMT 2025
by
admin
on
Mon Mar 31 21:27:40 GMT 2025
|
| Record UNII |
5QN16UUF80
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000127718
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
DTXSID901032334
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
C119561
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
5QN16UUF80
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
m5754
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | Merck Index | ||
|
452501
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
SUB33805
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
488-43-7
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
1313187
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | RxNorm | ||
|
5QN16UUF80
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY | |||
|
207-677-3
Created by
admin on Mon Mar 31 21:27:40 GMT 2025 , Edited by admin on Mon Mar 31 21:27:40 GMT 2025
|
PRIMARY |